While not officially approved for weight loss, some providers prescribe it off-label to support modest reductions in weight
Ethanol metabolism, CYP2E1 induction, compromised antioxidant defenses, mitochondrial injury, activation of Kupffer and stellate cells, hypoxia, and iron overload can all contribute to the alcohol-induced oxidative environment
Tirzepatide: Offers greater appetite suppression than GLP-1 drugs alone Enhances insulin sensitivity Delivers industry-leading weight loss outcomes Can also improve cardiovascular and metabolic health Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight management
Because Mounjaro itself is approved only for diabetes, many doctors turn to compounded tirzepatide or other legally prescribed formulations for patients without diabetes
Once the design is approved, we help transition the solution into a repeatable production model
95% CI, 0.95-4.91)